Modulation of Angiogenesis and Progelatinase a by Thrombin Receptor Mimetics and Antagonists

References

• Tsopanoglou N. E., Pipili-Synetos E., Maragoudakis M. E. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol. 1993; 264: C1302–1307, Cell Physiol. 33
   PubMed Web of Science ®Google Scholar
• Haralabopoulos G. C., Grant D. S., Kleinman H. K., Maragoudakis M. E. Thrombin promotes endothelial cel alignment in Matrigel in vitro and angiogenesis in vivo. Am. J. Physiol. 1997; 273: C239–C242
   PubMed Web of Science ®Google Scholar
• Tsopanoglou N. E., Pipili-Synetos E., Maragoudakis M. E. On the mechanism of thrombin-induced angiogenesis. Potentiation of VEGF activity on endothelial cells by up-regulation of its receptors. J. Biol. Chem. 1999; 274: 23969–23976
   PubMed Web of Science ®Google Scholar
• Vu T.-K., Hung D., Wheaton V., Coughlin S. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057–1068
   PubMed Web of Science ®Google Scholar
• Nierodzik M. L., Kajumo F., Karpatikin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res. 1992; 52: 3267–3272
   PubMed Web of Science ®Google Scholar
• Even-Ram S., Usiely B., Cohen P., Grisaru-Granovsky S., Maoz M., Ginzburg Y., Reich R., Vlodavsky I., Bar-Shavit R. Thrombin receptor expression in malignant and physiological invation processes. Nat. Med. 1998; 4: 909–914
   PubMed Web of Science ®Google Scholar
• Sorensen H. T., Mellem K. L., Steffensen F. H., Olsen J. H., Nielsen G. L. The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N. Engl. J. Med. 1998; 338: 1169–1173
   PubMed Web of Science ®Google Scholar
• Sloan B. F., Rozhin J., Johnson K., Taylor H., Crissman J. D., Honn K. V. Cathepsin B: association with plasma membrane in metastatic tumours. Proc. Natl. Acad. Sci. (USA) 1986; 83: 2483–2487
   PubMed Web of Science ®Google Scholar
• Rickles F. R., Edwards R. L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62(1)14–31
   PubMed Web of Science ®Google Scholar
• Maragoudakis M. E., Pipili-Synetos E., Sakkoula E., Pana-Giotopoulos D., Craniti N., Matsoukas J. Inhibition of TRAP-induced angiogenesis by the tripeptide Phe-Pro-Arg, a thrombin-receptor-derived peptide analogue. LiPS 1996; 3: 227–232
   Google Scholar
• Panagiotopoulos D., Matsoukas J., Alexopoulos K., Zebeki A., Mavromoustakos T., Saiffedine M., Hollenberg M. Synthesis and activities of cyclic thrombin-receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence containing D-Phe and/or D-Arg. LiPS 1996; 3: 233–240
   Google Scholar
• Alexopoulos K., Fatseas P., Melissari E., Vlahakow D., Smith J., Mavromoustakos T., Seifeddine M., Moore G., Hollenberg M., Matsoukas J. Design and synthesis of thrombin-receptor non-peptide mimetics utilizing a piperazine scaffold. Biorg. & Med. Chem. 1998; 7: 1033–1041
   Web of Science ®Google Scholar
• Jaffe E. A., Nachman R-L., Becker C. G., Minick C. C.R.R. Mimick CR culture of human endothelial cells derived from umbilical veins. Identification and immunological reaction. J. Clin. Invest. 1973; 52: 2745–2756
   PubMed Web of Science ®Google Scholar
• Heussen G., Dowdle E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem 1980; 102: 192–202
   Google Scholar
• Zucker S., Conner C., Massimo B., Ende H., Drew M., Seiki M., Bahou W. F. Thrombin induces the activation of progelatinase A in vascular endothelial cells. J. Biol. Chem. 1995; 270: 23730–23738
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis. Adv. Cane. Res. 1985; 43: 172–203
   Google Scholar
• Maragoudakis M. E., Panoutsacopoulou M., Sarmonika M. Rate of basement membrane biosynthesis as an index of angiogenesis. Tissue and Cell 1988; 20: 531–539
   PubMed Web of Science ®Google Scholar
• Maragoudakis M. E., Haralabopoulos G. C., Tsopanoglou N. E., Pipili-Synetos E. Validation of collagenous protein synthesis as an index of angiogenesis with the use of morphological methods. Microvascular Res. 1995; 50: 215–222
   PubMed Web of Science ®Google Scholar
• Duhamel-Clerin E., Orvain C., Lanza F., Cazenave J-P., Klein-Soyer C. Thrombin-receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3 in human endothelial cells. Atheroscl., Thromb. and Vasc. Biology 1997; 17: 1931–1938
   PubMed Web of Science ®Google Scholar
• Tapparelli C., Metternich R., Ehrhardt C., Cook N. S. Synthetic low molecular weight thrombin inhibitors: molecular design and pharmacological profile. TIPS 1993; 14: 366–376
   PubMed Web of Science ®Google Scholar
• Li W. W., Li V. W., Casey R., Tsakayannis D., Kruger E. A., Lee A., Sun Y. L., Bonar C. A., Cornelius S. Clinical trials of angiogenesis based therapies: overview and new quiding principles. In Angiogenesis: Models, Modulators and Clinical Applications, M. E. Maragoudakis. Plenum Press. 1998; 475–492
   Google Scholar
• Matsoukas J., Panagiotopoulos D., Keramida M., Mavromoustakos T., Yamdagni R., Qiao W., Moore G., Saiffed-Dine M., Hollenberg M. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: Importance of the Phe/Arg relative conformation and the primary amino group for activity. J. Med. Chem. 1996; 39: 3585–3591
   PubMed Web of Science ®Google Scholar
• Matsoukas J., Hollenberg M., Mavromoustakos T., Panagiotopoulos D., Alexopoulos K., Yamdagni R., Wu Q., Moore G. Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: Evidence for cyclic bio-active conformation. J. Prot. Chem. 1997; 16: 113–131
   PubMedGoogle Scholar